With Cancer Genome Atlas Research Data, Researchers Refine Prognostic Signatures for Ovarian Cancer | GenomeWeb

NEW YORK (GenomeWeb News) – Drawing on Cancer Genome Atlas Research data, the University of Texas MD Anderson Cancer Center's Roel Verhaak and an international team of researchers expanded on subtype and survival gene expression signatures for patients with high-grade serous ovarian carcinoma.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.